Epidemiology & Real-World Evidence of SUL-DUR in Special Populations with CRAB Infection funds researchers studying CRAB and SUL-DUR in adult patient groups in China to assess disease burden and treatment outcomes.
Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia supports healthcare teams' local quality improvement projects to improve diagnosis, treatment, and adult care.
NIH funding supports a four-center clinical research network to design, implement, and manage studies addressing pivotal clinical questions about antimicrobial resistance; a clinical trial is required.
Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI) supports researchers studying diagnostic-guided treatment of resistant infections to assess timeliness and effectiveness.
Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections funds independent researchers studying treatment outcomes to improve patient care.
Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment Options funds researchers’ studies to assess real-world treatment outcomes.